Alliance Wealth Advisors (Utah)’s Regeneron Pharmaceuticals REGN Stock Holding History

Alliance Wealth Advisors (Utah)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Sell	442 -235	-35%	-$160K	0.05%	197
2026 Q1	$523K	Sell	677 -300	-31%	-$230K	0.11%	130
2025 Q4	$754K	Sell	977 -244	-20%	-$166K	0.16%	133
2025 Q3	$687K	Buy	1,221 +274	+29%	+$155K	0.16%	144
2025 Q2	$497K	Buy	947 +314	+50%	+$175K	0.12%	165
2025 Q1	$401K	Buy	633 +285	+82%	+$196K	0.1%	179
2024 Q4	$248K	Buy	+348	New	+$292K	0.06%	234

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Alliance Wealth Advisors (Utah)'s REGN Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) reduced its Regeneron Pharmaceuticals (REGN) stake by 35% in Q2 2026, selling an estimated $160K and leaving 442 shares worth $276K. The position accounts for 0.05% of the portfolio, ranked #197.

Alliance Wealth Advisors (Utah) first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $754K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Alliance Wealth Advisors (Utah) held 442 shares of Regeneron Pharmaceuticals worth $276K as of Q2 2026.
Alliance Wealth Advisors (Utah) sold 235 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $160K.
Regeneron Pharmaceuticals made up 0.05% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #197 holding.
Alliance Wealth Advisors (Utah) first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Alliance Wealth Advisors (Utah)'s Regeneron Pharmaceuticals position peaked at $754K in Q4 2025.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.